Tau immunotherapies: Lessons learned, current status and future considerations
Author:
Funder
EMS
NIH
NYU Alzheimer's Disease Center
Publisher
Elsevier BV
Subject
Cellular and Molecular Neuroscience,Pharmacology
Reference175 articles.
1. Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency;Agadjanyan;Mol. Neurodegener.,2017
2. Preclinical characterization of an antibody [Ly3303560] targeting aggregated tau;Alam;Alzheimer's Dementia,2017
3. Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae;Albayram;Nat. Commun.,2017
4. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody;Albert;Brain,2019
5. Direct action of immunoglobulin G on primary sensory neurons through Fc gamma receptor I;Andoh;Faseb. J.,2004
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Specific serum autoantibodies predict the development and progression of Alzheimer’s disease with high accuracy;Brain, Behavior, and Immunity;2024-01
2. Role of Tau protein in long COVID and potential therapeutic targets;Frontiers in Cellular and Infection Microbiology;2023-10-25
3. Increased tau expression in theAPOE4blood-brain barrier model is associated with reduced anti-tau therapeutic antibody deliveryin vitro;2023-10-25
4. Tau-targeting therapies for Alzheimer disease: current status and future directions;Nature Reviews Neurology;2023-10-24
5. Personalised Regional Modelling Predicts Tau Progression in the Human Brain;2023-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3